denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: SOBI, Novartis, and Rigel Pharmaceuticals, Inc.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Treatment Considerations
Hematology Disease Topics & Pathways:
Treatment Considerations
Friday, December 6, 2024: 11:00 AM-2:00 PM
Marriott Grand Ballroom 11-13
(Marriott Marquis San Diego Marina)
Speakers:
Rachael F. Grace, MD, MMSc, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
,
Hanny Al-Samkari, MD, Massachusetts General Hospital
and
Michael D Tarantino, MD, Bleeding and Clotting Disorders Institute
Disclosures:
Grace: Agios, Sobi, Novartis: Research Funding; Agios, Sanofi, Sobi: Consultancy. Al-Samkari: Vaderis: Research Funding; Alpine: Consultancy; Alnylam: Consultancy; Novartis: Consultancy, Research Funding; Sobi: Consultancy, Research Funding; Pharmacosmos: Consultancy; argenx: Consultancy; Amgen: Consultancy, Research Funding; Agios: Consultancy, Research Funding. Tarantino: Amgen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Genentech: Consultancy, Research Funding; Novo Nordisk: Consultancy; Novartis: Consultancy; Octapharma: Consultancy, Research Funding; Sanofi: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Sobi: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Takeda: Consultancy, Research Funding.
Expert faculty will focus on the important pillars related to the comprehensive and holistic care of patients with ITP, including disease-centered care, treatment-related considerations, and prioritizing patient-centered care. Faculty will expand on the mechanism of the disease and its causes, and the importance of a holistic approach. Presentations will revolve around the importance of defining clinical features and diagnostic criteria that are critical to diagnosis and treatment planning. A collaborative panel discussion will include insights into efficacy and safety data on current treatment options, choosing the best option for patients, and managing adverse events. In addition, the importance of patient perspectives and the caregiver’s roles will be discussed and how they can be integrated into collaborative decision-making.
See more of: Friday Satellite Symposia